Uncover key drivers, emerging technologies, and competitive movements shaping the rare disease genetic testing market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Rare Disease Genetic Testing Market?

The rare disease genetic testing market has experienced significant expansion in recent years. This market is projected to increase from $1.03 billion in 2024 to $1.17 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 13.6%. Historically, this growth has been driven by increased public awareness of rare genetic disorders, a rising demand for early and accurate diagnoses, greater government funding for rare disease research, enhanced availability of genetic testing services, growing investments in precision medicine, and an increasing incidence of rare genetic conditions.

The rare disease genetic testing market is projected for substantial growth in the coming years, with its size expected to reach $1.93 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 13.3%. This expansion during the forecast period is fueled by several factors, including the increasing integration of next-generation sequencing, a heightened focus on personalized medicine, augmented investments in genetic research, the development of healthcare infrastructure in emerging markets, an uptick in diagnostic testing, the rise in hereditary cancer testing, and a growing need for non-invasive diagnostic solutions. Prominent trends anticipated in this period encompass improvements in genome editing technologies, sophisticated bioinformatics tools for genetic data analysis, novel developments in multi-gene panel testing, progress in portable genetic testing devices, and innovative sample collection techniques.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27404&type=smp

What Market Forces Are Contributing To The Growth Of The Rare Disease Genetic Testing Market?

A rise in genetic disorders is anticipated to fuel the expansion of the rare disease genetic testing market in the future. These disorders are defined as medical conditions resulting from DNA irregularities in an individual, which can be passed down from one or both parents or develop from novel mutations. The prevalence of genetic disorders is climbing, partly due to advancing parental age, given that older parents face an elevated risk of transmitting genetic mutations to their offspring. Rare disease genetic testing aids in diagnosing genetic disorders by pinpointing specific mutations, thereby facilitating precise and prompt detection. Furthermore, it assists in tailored treatment planning, leading to better patient care and improved long-term health results. As an illustration, in May 2024, data from the National Health Service, a government department in the UK, indicated that 17,000 people suffer from sickle cell disease, an inherited genetic blood disorder, with approximately 250 new cases identified annually. Consequently, the surge in genetic disorders is propelling the growth of the rare disease genetic testing market.

Which Segmentation Factors Are Critical In The Rare Disease Genetic Testing Market Analysis?

The rare disease genetic testing market covered in this report is segmented

1) By Disease Type: Immunological Disorders, Cardiovascular Disorders, Neurological Disease, Endocrine And Metabolism Disorders Diseases, Hematological Diseases, Dermatological Disease, Other Disease Types

2) By Technology: Next-Generation Sequencing, Sanger Sequencing, Polymerase Chain Reaction Based Testing, Array Based Testing, Fluorescence In Situ Hybridization, Other Technologies

3) By Specialty: Molecular Genetic Tests, Chromosomal Genetic Tests, Biochemical Genetic Tests

4) By End-User: Hospitals And Clinics, Research Laboratories And Contract Research Organizations, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Immunological Disorders: Autoimmune Disorders, Allergic Conditions, Primary Immunodeficiency Disorders, Inflammatory Disorders

2) By Cardiovascular Disorders: Congenital Heart Defects, Cardiomyopathies, Aortic Aneurysms, Pulmonary Hypertension

3) By Neurological Disease: Neurodegenerative Disorders, Neuromuscular Disorders, Epileptic Syndromes, Movement Disorders

4) By Endocrine And Metabolism Disorders Diseases: Inherited Metabolic Disorders, Thyroid Disorders, Adrenal Disorders, Diabetes Related Genetic Conditions

5) By Hematological Diseases: Hemophilia, Thalassemia, Sickle Cell Disease, Clotting Disorders

6) By Dermatological Disease: Genetic Skin Disorders, Connective Tissue Disorders, Pigmentary Disorders, Keratinization Disorders

7) By Other Disease Types: Skeletal Dysplasia, Renal Genetic Disorders, Ophthalmic Genetic Conditions, Gastrointestinal Genetic Conditions

What Are The Dominant Trends Currently Seen In The Rare Disease Genetic Testing Market?

Leading companies in the rare disease genetic testing market are concentrating on developing technologically advanced solutions, such as digital genomics platforms, to boost the speed, accuracy, and scalability of rare disease diagnosis. Digital genomics platforms are sophisticated software systems that integrate genomic data analysis, interpretation, and reporting to streamline and accelerate genetic testing and diagnosis processes. For example, in March 2025, Strand Life Sciences Private Limited, an India-based computer software company, launched the StrandOmics Portal, a digital platform designed to enhance the efficiency and precision of rare disease diagnosis. This portal offers clinicians deep insights into genetic variants, enabling quicker and more accurate diagnoses. It supports advanced variant interpretation, including prenatal diagnostics, and facilitates independent reviews of genetic data. This launch demonstrates a strong commitment to advancing precision medicine and equipping healthcare professionals with effective tools to improve patient outcomes.

Which Organizations Are At The Forefront Of The Rare Disease Genetic Testing Market?

Major companies operating in the rare disease genetic testing market are Thermo Fisher Scientific Inc., Quest Diagnostics Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Natera Inc., OPKO Health Inc., Myriad Genetics Inc., Fulgent Genetics Inc., BioReference Laboratories Inc., Invitae Corporation, Ambry Genetics Corporation, Centogene N.V., Baylor Genetics Company, PreventionGenetics, Blueprint Genetics Oy, Realm IDX Inc., Artemis DNA Inc., BGI Genomics Co. Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/rare-disease-genetic-testing-global-market-report

Which Region Is Leading Innovation In The Rare Disease Genetic Testing Market?

North America was the largest region in the rare disease genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rare disease genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27404&type=smp

Browse Through More Reports Similar to the Global Rare Disease Genetic Testing Market 2025, By The Business Research Company

Data Wrangling Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/data-wrangling-global-market-report

Data Catalog Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/data-catalog-global-market-report

Datafication Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/datafication-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model